News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Series A
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
Two weeks after Vertex’s Phase III data for VX-548 reenergized the field, Latigo Biotherapeutics announced $135 million in Series A funds to push its own NaV1.8 inhibitor into Phase II.
February 13, 2024
·
3 min read
·
Heather McKenzie
PRESS RELEASES
Press Releases
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
May 11, 2026
·
4 min read
Press Releases
Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients
May 6, 2026
·
5 min read
Press Releases
Picard Medical Announces Pricing of $5 Million Offering
May 5, 2026
·
5 min read
Press Releases
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
May 5, 2026
·
4 min read
Press Releases
Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential
May 4, 2026
·
5 min read
Press Releases
Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations
May 4, 2026
·
6 min read
Press Releases
Photon Raises $16M Series A to Give Patients Control Over Their Prescriptions and Bring Transparency to Pharmacy
April 30, 2026
·
6 min read
Press Releases
Axoft Secures $55M Series A to Advance Clinical Trials Globally for its Bio-Inspired, Implantable Brain-Computer Interface
April 29, 2026
·
5 min read
Press Releases
Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million
April 29, 2026
·
4 min read
Press Releases
Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline
April 28, 2026
·
3 min read
Press Releases
mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
April 28, 2026
·
3 min read
Press Releases
Lighthouse Pharmaceuticals Closes $12 Million Series A Financing Led by Double Point Ventures
April 28, 2026
·
2 min read
Press Releases
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
April 27, 2026
·
4 min read
Press Releases
Deep Blue Medical Closes Oversubscribed $5.6M Series A and Elevates Veteran Leader to COO
April 21, 2026
·
2 min read
Press Releases
Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development
April 15, 2026
·
3 min read
Press Releases
Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases
April 15, 2026
·
7 min read
Press Releases
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
April 10, 2026
·
4 min read
Press Releases
Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform
April 6, 2026
·
3 min read
Press Releases
Scala Biodesign Raises $16M Series A Financing to Accelerate Development of Protein-Based Products with ScalaOS
March 31, 2026
·
4 min read
Press Releases
Gilgamesh Pharma Closes Oversubscribed $60 Million Series A to Develop Next Generation Neuropsychiatric Therapies
March 24, 2026
·
3 min read
